Since thiazolidinediones are also known as insulin-sensitizing agents used in the treatment of type 2 diabetes as effective agents for attenuating insulin resistance, compounds can be tested for their anti-inflammatory and antidiabetic activities. This evidence concerns the gene INS and Insulin resistance.